ARTICLE | Company News
ViraTherapeutics, Boehringer Ingelheim deal
October 3, 2016 7:00 AM UTC
Boehringer and ViraTherapeutics partnered to jointly develop ViraTherapeutics’ oncolytic virus therapy platform and its lead cancer candidate VSV-GP. ViraTherapeutics will be responsible for preclini...